Clinical Trials List
2022-02-01 - 2027-12-31
Phase III
Not yet recruiting3
Recruiting1
ICD-10G63
Polyneuropathy in diseases classified elsewhere
ICD-10G65.0
Sequelae of Guillain-Barre syndrome
ICD-10G65.1
Sequelae of other inflammatory polyneuropathy
ICD-10G65.2
Sequelae of toxic polyneuropathy
ICD-9357.4
Polyneuropathy in other diseases classified elsewhere
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ming-Jen Lee Division of Neurology
- 葉馨僑 Division of Neurology
- Jen Jen and I Su Division of Neurology
- 林昭文 Division of Ophthalmology
- SUNG-TSANG HSIEH Division of Neurology
- HSUEH-WEN HSUEH Division of Neurology
- SHIN-JOE YEH Division of Neurology
- LI-KAI TSAI Division of Neurology
- YEN-HUNG LIN Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ching-Hua Lu Lu Division of Neurology
- Kang-Hsu Lin Division of Neurology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 呂榮國 無
- 洪國竣 Division of Neurology
- 張宏旭 Division of Neurology
- 謝珮甄 Division of Neurology
- Hong-Chou Kuo Division of Neurology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 賴冠霖 Division of Neurology
- Kon-Ping Lin Division of Neurology
- Mei-Ju Chen Division of Ophthalmology
- Yi-Chu Liao Division of Neurology
- Wen-Chung Yu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
200 participants
